NewsBenzingaGyre Therapeutics、2026年度売上高ガイダンスを1億50万ドル~1億1,100万ドルで据え置き、予想の1億950万ドルを下回ると表明 Gyre Therapeutics、2026年度売上高ガイダンスを1億50万ドル~1億1,100万ドルで据え置き、予想の1億950万ドルを下回ると表明 Benzinga 2026.11.05 22:30 (GMT+0) Open on Benzinga Other news Israeli Shipping Giant ZIM Cashes In on Surging Freight Rates, Raises Outlook UBS Maintains Buy on Home Depot, Lowers Price Target to $417 Disney Posts Upbeat Q4, Analysts Raise Price Target Citing Theme Park Resilience StoneX Maintains Buy on Bitdeer Techs, Lowers Price Target to $15 Merck Pulls Plug On Acquired Drug after Safety Review UBS Maintains Neutral on Granite Point Mortgage Tr, Lowers Price Target to $3